BLAC stockholders approve business combination with OSR Holdings; name change to OSR Holdings, Inc.

OSR Holdings, Inc.

All proposals approved at Feb 13 special meeting; 93.95% quorum; 57,821 shares redeemed.
Transaction expected to close Feb 14 after foreign investment approval from Industrial Bank of Korea.
Post-close, OSR Holdings will own ~67% of OSR; additional 22% subject to put/call from 2026.
New tickers OSRH (common) and OSRHW (warrants) begin trading on Nasdaq Feb 18.
Nine directors elected; portfolio includes Phase 2 immunotherapy, age-related therapies, medical device distribution.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.